QSC PHARMA GRADE
🇮🇳 India Warehouse100-Count Pack
What is Bilypsa 4mg (1X10) (POSACONAZOLE)?
Extended-spectrum triazole antifungal for prophylaxis of invasive Aspergillus and Candida infections in immunocompromised patients, and treatment of certain refractory fungal infections.
How it Works
Inhibits fungal lanosterol 14-alpha-demethylase (CYP51), blocking ergosterol synthesis. Broadest spectrum of any oral azole — covers Zygomycetes (mucormycosis) unlike other azoles.
Quick Specs
| Form | Oral tablets — pre-dosed |
| Active Ingredient | POSACONAZOLE |
| Dose per Tablet | 4MG |
| Pack Size | 10×10 (100 tablets) |
| Storage | Room temperature (15–25°C), cool dry place |
| Shelf Life | 2–3 years (properly stored) |
Common Side Effects
Nausea, vomiting, diarrhea, headache, elevated liver enzymes, QT prolongation, hypokalemia.
Safety Warnings
⚠️ QT prolongation — caution with other QT drugs. Strong CYP3A4 inhibitor — multiple interactions. Hepatotoxicity monitoring. Suspension vs tablet have very different bioavailability characteristics.
Shipping: 🇮🇳 India Warehouse — international delivery
